| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692372 | Journal of Minimally Invasive Gynecology | 2017 | 31 Pages |
Abstract
Women with type II endometrial cancer submitted to MIS for hysterectomy experienced fewer complications and similar survival outcomes compared with those who underwent open surgery. When managed by an expert surgeon, a high-risk histological subtype should not be considered a contraindication for MIS. Further prospectively randomized studies are needed to definitively evaluate the safety and feasibility of MIS in early-stage type II endometrial cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Giorgia MD, Fabio PhD, Enrico MD, Gian Franco PhD, Stefano PhD, Giacomo MD, Stefano MD, Lorena MD, Jvan MD, Giorgia MD, Giovanni PhD, Francesco MD, PhD,